QUAIL-100

N/A

Report date: 2026/05/20 20:02:01
First In Class

Base Information

Drug NameQUAIL-100
Drug Alias NameQUAIL-100LGNA-100
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsUpdating
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaguna Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A